Skip to main content

Advertisement

Log in

Approach to Chronic Daily Headache

  • Headache (RB Halker, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Chronic daily headaches (CDH) is a descriptive term used for patients who experience headaches on at least 15 days or more out of the month; for at least 3 months, irrespective of the underlying headache etiology. It is a syndrome that affects many people, usually with an underlying primary headache disorder, leading to a reduction in quality of life. The two most common underlying primary headaches are migraines and tension-type headaches. The prevalence is about 4 %, and research is emerging on risk factors and comorbidities. The first step when approaching a patient with chronic daily headaches is to rule out secondary causes. Once that is done, the goal is to effectively reduce the days of headache through preventive treatment as well as complementary therapies. This also often involves limiting the use of abortive therapy to avoid medication-overuse headaches (MOH). The pathophysiology, although not fully understood, is thought to be related to central sensitization along with “neurogenic inflammation.” Chronic daily headaches can be difficult to treat and at times require a tertiary specialized center.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Halker RB, Hastriter EV, Dodick DW. Chronic daily headache: an evidence-based and systematic approach to a challenging problem. Neurology. 2011;76(7 Suppl 2):S37–43. Previous the review on the same subject.

    Article  PubMed  Google Scholar 

  2. Smitherman TA, Black AK, Davis CN. Treatment of PTSD and chronic daily headache. Curr Treat Options Neurol. 2014;16(10):312–014–0312–7. Important review on epidemiology and treatment of chronic daily headache.

    Article  Google Scholar 

  3. Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001;5(6):529–36.

    Article  CAS  PubMed  Google Scholar 

  4. Garza I, Schwedt TJ. Diagnosis and management of chronic daily headache. Semin Neurol. 2010;30(2):154–66. Comprehensive review.

    Article  PubMed  Google Scholar 

  5. Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin. 2001;17 Suppl 1:s4–12.

    Article  PubMed  Google Scholar 

  6. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443–54.

    Article  CAS  PubMed  Google Scholar 

  7. Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41(6):573–8.

    Article  CAS  PubMed  Google Scholar 

  8. Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960–9.

    Article  PubMed  Google Scholar 

  9. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32.

    Article  CAS  PubMed  Google Scholar 

  10. Radat F, Lanteri-Minet M, Nachit-Ouinekh F, Massiou H, Lucas C, Pradalier A, et al. The GRIM2005 study of migraine consultation in France. III: psychological features of subjects with migraine. Cephalalgia. 2009;29(3):338–50.

    Article  CAS  PubMed  Google Scholar 

  11. Peterlin BL, Tietjen GE, Brandes JL, Rubin SM, Drexler E, Lidicker JR, et al. Posttraumatic stress disorder in migraine. Headache. 2009;49(4):541–51.

    Article  PubMed  Google Scholar 

  12. Peterlin BL, Tietjen G, Meng S, Lidicker J, Bigal M. Post-traumatic stress disorder in episodic and chronic migraine. Headache. 2008;48(4):517–22.

    Article  PubMed  Google Scholar 

  13. Saper JR, Hamel RL, Lake 3rd AE. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005;25(7):545–6.

    Article  CAS  PubMed  Google Scholar 

  14. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain. 2005;119(1–3):49–55.

    Article  PubMed  Google Scholar 

  15. Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008;48(1):16–25.

    Article  PubMed  Google Scholar 

  16. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004;63(11):2022–7.

    Article  CAS  PubMed  Google Scholar 

  17. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497–506.

    Article  CAS  PubMed  Google Scholar 

  18. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998;279(5):381–3.

    Article  CAS  PubMed  Google Scholar 

  19. Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB. The classification of chronic daily headache in adolescents—a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache. 2005;45(5):582–9.

    Article  PubMed  Google Scholar 

  20. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache. 2004;44(7):684–91.

    Article  PubMed  Google Scholar 

  21. Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.

    Article  PubMed  Google Scholar 

  22. Westergaard ML, Glumer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014;155(10):2005–13.

    Article  PubMed  Google Scholar 

  23. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

    Article  Google Scholar 

  24. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic daily headache: identification of factors associated with induction and transformation. Headache. 2002;42(7):575–81.

    Article  PubMed  Google Scholar 

  25. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47(4):871–5.

    Article  CAS  PubMed  Google Scholar 

  26. Martelletti P, Katsarava Z, Lampl C, Magis D, Bendtsen L, Negro A, et al. Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain. 2014;15:47-2377–15-47.

    Google Scholar 

  27. Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26(9):1168–70.

    Article  CAS  PubMed  Google Scholar 

  28. Park JW, Moon HS, Kim JM, Lee KS, Chu MK. Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol. 2014;10(3):236–43.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004;62(5):788–90.

    Article  CAS  PubMed  Google Scholar 

  30. Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006;26(9):1106–14.

    Article  CAS  PubMed  Google Scholar 

  31. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3(8):475–83.

    Article  PubMed  Google Scholar 

  32. Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 2001;57(1):132–4.

    Article  CAS  PubMed  Google Scholar 

  33. Schwedt TJ, Dodick DW. Advanced neuroimaging of migraine. Lancet Neurol. 2009;8(6):560–8.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Amoils S, Amoils S, Lester T, Woolford L, Gallagher L. The positive impact of integrative medicine in the treatment of recalcitrant chronic daily headache: a series of case reports. Glob Adv Health Med. 2014;3(4):45–54.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Hickman C, Jacobson D, Melnyk BM. Randomized controlled trial of the acceptability, feasibility, and preliminary effects of a cognitive behavioral skills building intervention in adolescents with chronic daily headaches: a pilot study. J Pediatr Health Care. 2014;29(1):5–16.

    Article  PubMed  Google Scholar 

  36. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.

    Article  CAS  PubMed  Google Scholar 

  37. Lipton RB, Bigal ME, Diamond M, AMPP Advisory Group, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.

    Article  CAS  PubMed  Google Scholar 

  38. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. Disability in strategies of care study group. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) study: a randomized trial. JAMA. 2000;284(20):2599–605.

    Article  CAS  PubMed  Google Scholar 

  39. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag Health Studies. Pain. 2012;153(1):56–61.

    Article  PubMed  Google Scholar 

  40. Smith TR, Stoneman J. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management. Drugs. 2004;64(22):2503–14.

    Article  CAS  PubMed  Google Scholar 

  41. Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71(22):1821–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Huma U. Sheikh declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huma U. Sheikh.

Additional information

This article is a part of the Topical Collection on Headache

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheikh, H.U. Approach to Chronic Daily Headache. Curr Neurol Neurosci Rep 15, 4 (2015). https://doi.org/10.1007/s11910-015-0528-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-015-0528-2

Keywords

Navigation